Erectile Dysfunction Drug Could Improve Raynaud’s Symptoms Associated with Scleroderma PDF Print E-mail
Sunday, 07 November 2010 20:48
Adding tadalafil (Cialis®; Adcirca®) to the treatment of people with Scleroderma can improve Raynaud’s phenomenon symptoms and heal and prevent hand and finger ulcers associated with it, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

Scleroderma (more formally called systemic sclerosis) is a rheumatic disease that results in the thickening and tightening of skin, as well as a build-up of scar tissue and damage to internal organs. Scleroderma is a relatively uncommon problem, affecting only 200 to 300 people per million in the U.S. Some 12 to 20 new cases per million are diagnosed annually. Effective treatments are available for some forms of the disease, although scleroderma is not yet curable.

The majority of patients with scleroderma also suffer from Raynaud's phenomenon – structural damage of the blood vessels that cause them to react abnormally to the cold. Raynaud’s phenomenon is commonly marked by discoloration of the hands, fingers and toes. This occurs due to poor blood flow and, in severe cases, can lead to damage such as finger ulcers, gangrene and scarring. These problems may adversely affect the functioning of the hands and quality of life during winter months.

Researchers recently completed a study to evaluate the effectiveness of adding tadalafil, a drug that can increase arterial blood flow and is commonly used to treat erectile dysfunction, to treat Raynaud's phenomenon in people with scleroderma. They studied 53 patients—of which 50 were women—whose average age was almost 37 years and who had suffered from scleroderma, on average, for almost six years. Twenty-six of the participants had limited scleroderma (which only occurs in the forearms, hands, legs, feet and face) and 27 had diffuse scleroderma (which can affect almost any area of the body). All participants met the American College of Rheumatology’s criteria for scleroderma diagnosis and had at least four Raynaud’s attacks per week.

The participants were monitored for one week to determine the initial severity of their disease and then were placed into two groups. The first group, of 26 participants, received placebo to take every-other-day in addition to their usual vasodilators (medication used to relax and widen blood vessels). The second group, of 27 participants, was given 20mg of tadalafil to take every-other-day in addition to their existing vasodilators. Participants in both groups did not know what treatment they were receiving and followed their treatment assignment for eight weeks.

Researchers then monitored the progress of each participant. They noted the number of daily Raynaud’s attacks and other measures of Raynaud’s, including the length of each individual attack, healing of existing hand and finger ulcers, appearance of new finger ulcers and improvement in scleroderma symptoms based on health and quality of life assessment questionnaires.

Researchers noticed that improvement in the tadalafil group was significantly better than in the placebo group. At the beginning of the study, 18 patients in the tadalafil group had ulcers as compared to 13 patients in the placebo group. Following treatment with tadalafil, 14 out of 18 of those patients healed completely as compared to five out of 13 patients in the placebo group.

Further results revealed that new ulcers appeared in only one patient in the tadalafil group as compared to nine patients in the placebo group. Additionally, other symptoms such as dyspnea (difficulty breathing), Raynaud’s phenomenon and digital ulcers were greatly improved in those taking tadalafil. Finally, researchers noted that side effects were similar in both groups and no serious side effects were observed.

These results led researchers to believe that adding tadalafil to existing Raynaud's phenomenon therapy may be of great benefit to people with scleroderma.

“Tadalafil, in combination with other vasodilators, not only improves the number, duration and severity of Raynaud’s attacks, but also heals the existing digital ulcers as compared to placebo,” explains Vikas Agarwal, MD; associate professor of clinical immunology at the Sanjay Gandhi Postgraduate Institute of Medical Sciences and lead investigator in the study. “In addition to preventing the development of new digital ulcers, tadalafil in combination with other vasodilators marks the beginning of new phase of oral therapeutic options available for severe scleroderma.”

Patients should talk to their rheumatologists to determine their best course of treatment.

Source: Newswise (2010), "Erectile Dysfunction Drug Could Improve Raynaud’s Symptoms Associated with Scleroderma"; full article can be viewed here.
 
More articles :

» Analytical Chemistry Used In Systemic Sclerosis Study

Scientists have used methods to identify new target autoantigens in patients with systemic sclerosis (SSc).The study, published by , stated that antinuclear antibodies (ANA) can normally be found in 90 per cent of SSc patients with the use of...

» Teen To Graduate, Despite Fatal Disease

A rare and life threatening medical disorder has kept a Portsmouth teen out of school and unable to walk for months, but Wednesday night he will walk the stage at his graduation. Wednesday night, families will be filing into the N-Telos pavilion in...

» Types of Stem Cell Treatments for Scleroderma

is a slowly debilitating terminal illness that robs the skin, limbs and vital organs through the process of pain upon exposure to cold and the tightening, thickening and in-elasticity of the skin. Scleroderma deposits connective tissue in places...

» Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes

Danilo Bretas de Oliveira, Gabriel Magno de Freitas Almeida, Antonio Carlos Martins Guedes, Flavia Patrıcia Sena Teixeira Santos, Claudio Antonio Bonjardim, Paulo Cesar Peregrino Ferreira, and Erna Geessien KroonReceived 15 June 2011; Revised 10...

» Management

Our Management Team or Executive Committee is presently responsible for the daily operations of the Scleroderma Care Foundation, realizing its vision, and similarly ensuring its growth and future success. Adelwyn Holder, Co-Founder &...

» Researchers Find Small Group Of ANA & RP Negative Patients

There exists a very small subgroup of patients with (SSc) who lack circulating (ANA) and who do not have Raynaud's phenomenon (RP), research shows. These patients also fail to meet any of the diagnostic criteria for known SSc mimics.The...

Comments  

 
0 #5 Doug Suever 2012-06-25 20:21
I was diagnosed with Systemic Sclerosis or Schleroderma and Raynaud's in 2010. I also have suffered my entire life with allergies. Please contact me if you are struggling with loss of energy and being ill with colds (mine were due to immune suppresants such as azathioprine and steroids such as prednisone). If your health is fairly stable but you still have these lingering problems, I may be able to help. Call me at 541-429-0778 or email me at . Good luch to ALL of you! Doug
Report to administrator
 
 
-1 #4 Wholesale NBA Hats 2012-05-24 23:05
Thank you for your blog. And, New Era Jordan Hats according to all of us to purchase, and a new book of Thomas, their opinions inches NFL Snapback Caps short article about the real money is the answer to all questions. In fact, Wholesale NBA Hats from a careful game of mind always. Of course, she is eating and fear, women of spirit for all the work and we will focus on,thank you very much!
Report to administrator
 
 
-2 #3 Julia alrn 2012-02-27 05:18
I like this post very much, You have defined it very simply for so I understand what you say, In this post your writing level is also excellent to us. This is great issue you have done on this topic really very well. Generic Viagra
Report to administrator
 
 
+2 #2 Sooze 2012-01-25 13:18
I am taking this for PH and have found it does help and also helps with digestion which was a huge problem for me with CREST.
Report to administrator
 
 
+2 #1 MilenaS 2011-12-19 10:12
A very interesting and promising experiment. Let us believe it will lead to the positive results in the treatment of Raynaud’s Symptoms Associated with Scleroderma. It would be perfect that erectile dysfunction drugs would be used for the alternative purposes and would cause benefit to people suffering from other diseases as well. Thank you for sharing.
Report to administrator